[Immunization in allergic patients. 2].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D022121:Cholera Vaccines / Q000009:adverse effects; D003888:Desensitization, Immunologic; D006474:Hemorrhagic Disorders / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000150:complications* / Q000188:drug therapy; D007252:Influenza Vaccines / Q000009:adverse effects; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects; D012900:Smallpox Vaccine; D013745:Tetanus Toxoid / Q000009:adverse effects; D014436:Typhoid-Paratyphoid Vaccines / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects*; D015004:Yellow Fever / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D022121:Cholera Vaccines; D006634:Histamine H1 Antagonists; D007252:Influenza Vaccines; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D012900:Smallpox Vaccine; D013745:Tetanus Toxoid; D014436:Typhoid-Paratyphoid Vaccines
Schutzimpfungen bei Allergikern. 2.